CARDIOLOGÍA
Hospital Universitario La Fe
Valencia, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Fe (47)
2024
-
Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives
Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651
2023
-
Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care
Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269
-
Myocardial revascularization failure among patients requiring cardiac catheterization and secondary revascularization in contemporary clinical practice: Results of the REVASEC multicenter registry
Catheterization and Cardiovascular Interventions, Vol. 102, Núm. 4, pp. 608-619
-
Selection of the best of 2022 in familial heart disease and cardiovascular genetics
REC: CardioClinics, Vol. 58, pp. S68-S73
-
Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)
Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031
-
Spanish catheter ablation registry. 22nd official report of the Heart Rhythm Association of the Spanish Society of Cardiology (2022)
Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 910-921
2022
-
Design and Rationale for a Real-World Prospective, Multicenter Registry of Myocardial Revascularization Failure and Secondary Revascularization: The REVASEC Study
Cardiovascular Revascularization Medicine, Vol. 40, pp. 50-56
-
Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry
ESC Heart Failure, Vol. 9, Núm. 4, pp. 2189-2198
-
Left atrial appendage closure with the II generation Ultraseal device: An international registry. The LIGATE study
Catheterization and Cardiovascular Interventions, Vol. 100, Núm. 4, pp. 620-627
-
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial
European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588
-
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301
-
Selection of the best of 2021 in familial heart disease and cardiovascular genetics
REC: CardioClinics, Vol. 57, pp. S54-S59
-
Temporal trend and potential impact of angiotensin receptor neprilysin inhibitors on transcatheter edge-to-edge mitral valve repair
Revista Espanola de Cardiologia, Vol. 75, Núm. 12, pp. 1001-1010
2021
-
A 3-Biomarker 2-Point-Based Risk Stratification Strategy in Acute Heart Failure
Frontiers in Physiology, Vol. 12
-
Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction
Journal of the American College of Cardiology, Vol. 78, Núm. 7, pp. 643-662
-
Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation
International Journal of Cardiology, Vol. 345, pp. 29-35
-
Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak
Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 927-937
-
Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic
Cardiovascular Diabetology, Vol. 20, Núm. 1
-
Percutaneous mitral valve repair: Outcome improvement with operator experience and a second-generation device
Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-10
-
Prognostic role of tapse to pasp ratio in patients undergoing mitraclip procedure
Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-13